SYLVIA YOON: Open Payments
NPI 1568919744 · DUARTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$487 in 17 payments from 6 companies in 2025. Trend: 2023 $155 · 2024 $331 · 2025 $487
Food & beverage: $487
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 10 | $256 |
| Melinta Therapeutics, LLC | 2 | $63 |
| GENZYME CORPORATION | 1 | $55 |
| Astellas Pharma US Inc | 2 | $46 |
| Alexion Pharmaceuticals, Inc. | 1 | $36 |
| GlaxoSmithKline, LLC. | 1 | $32 |
Products named: Vanflyta, Rezzayo, WAYRILZ, Vyloy, OJJAARA.
Industry payments across CA — which companies pay providers there.
